Sign in Subscribe
Class action lawsuits

Rocket Pharmaceuticals Securities Class Action Lawsuit Filed

Strategic Insights

— 1 min read

Investors of Rocket Pharmaceuticals, Inc. (RCKT) between February 27, 2025, and May 26, 2025, may be entitled to compensation due to allegedly misleading statements made by the company. The lawsuit was filed by the Rosen Law Firm, a global investor rights law firm, which reminds investors of the August 11, 2025, lead plaintiff deadline. The firm has a track record of securing large settlements for investors, including the largest ever securities class action settlement against a Chinese company at the time.

Key Takeaways:

  • The lawsuit alleges that Rocket Pharmaceuticals made misleading statements about the safety and clinical trial protocol of its RP-A501 treatment, while concealing the risk of serious adverse events, including deaths.
  • The company allegedly amended the trial's protocol without disclosing this critical update to shareholders, causing them to purchase securities at artificially inflated prices.
  • Investors who purchased Rocket Pharmaceuticals securities between February 27, 2025, and May 26, 2025, may be entitled to compensation through a contingency fee arrangement.
  • The Rosen Law Firm, a global investor rights law firm, represents investors throughout the globe, focusing on securities class actions and shareholder derivative litigation.
  • The firm has consistently ranked high in securities class action settlements, with over $438 million secured for investors in 2019 alone.
  • The lawsuit has not yet certified a class, and investors may select their own counsel or remain as an absent class member.

Statistics:

  • $438 million: The amount secured for investors by the Rosen Law Firm in 2019 alone.
  • 2017: The year the Rosen Law Firm was ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements.
  • 2013: The year the Rosen Law Firm started ranking in the top 4 for securities class action settlements.
  • August 11, 2025: The deadline for investors to become the lead plaintiff in the lawsuit.

Sources:

  • Newsfile Corp. - July 21, 2025 - "Rocket Pharmaceuticals, Inc. (RCKT) Securities Class Action Lawsuit Filed - Lead Plaintiff Deadline is August 11, 2025"
  • The Rosen Law Firm, P.A. - [No specific source date] - "About Us"

Read more